Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ceritinib versus chemotherapy in ALK-positive lung cancer.

× No keyword cloud information.

2 in total

Review 1. Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.

Authors: Laird B Cameron; Nadia Hitchen; Elias Chandran; Tessa Morris; Renée Manser; Benjamin J Solomon; Vanessa Jordan
Journal: Cochrane Database Syst Rev Date: 2022-01-07

2. Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report.

Authors: Xuan Wu; Hanqiong Zhou; Zhen He; Zhe Zhang; Wen Feng; Jiuzhou Zhao; Haiyang Chen; Shuai Wang; Wei Wang; Qiming Wang
Journal: Transl Lung Cancer Res Date: 2020-12

2 in total

Ceritinib versus chemotherapy in ALK-positive lung cancer.

Review 1. Targeted therapy for advanced anaplastic lymphoma kinase (<I>ALK</I>)-rearranged non-small cell lung cancer.

2. Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report.